PTC
MEDP icon

Private Trust Company’s Medpace MEDP Stock Holding History

Private Trust Company’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.9K Sell
47
-4
-8% -$1.85K ﹤0.01% 1689
2026
Q1 		$24.5K Buy
51
+15
+42% +$7.68K ﹤0.01% 1607
2025
Q4 		$20.2K Buy
36
+18
+100% +$10.2K ﹤0.01% 1648
2025
Q3 		$9.26K Sell
18
-6
-25% -$2.62K ﹤0.01% 1935
2025
Q2 		$7.38K Sell
24
-5
-17% -$1.5K ﹤0.01% 1916
2025
Q1 		$8.84K Buy
29
+13
+81% +$4.37K ﹤0.01% 1844
2024
Q4 		$5.32K Buy
16
+11
+220% +$3.73K ﹤0.01% 1957
2024
Q3 		$1.67K Hold
5
– – ﹤0.01% 2167
2024
Q2 		$2.06K Hold
5
– – ﹤0.01% 2151
2024
Q1 		$2.02K Hold
5
– – ﹤0.01% 2113
2023
Q4 		$1.53K Sell
5
-25
-83% -$6.75K ﹤0.01% 2164
2023
Q3 		$7.26K Sell
30
-15
-33% -$3.84K ﹤0.01% 1724
2023
Q2 		$10.8K Sell
45
-5
-10% -$1.04K ﹤0.01% 1593
2023
Q1 		$9.4K Sell
50
-11
-18% -$2.27K ﹤0.01% 1603
2022
Q4 		$13K Sell
61
-5
-8% -$999 ﹤0.01% 1463
2022
Q3 		$10K Sell
66
-14
-18% -$2.23K ﹤0.01% 1457
2022
Q2 		$12K Buy
+80
New +$11.6K ﹤0.01% 1421

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Private Trust Company's MEDP Position: Q2 2026 in Review

Private Trust Company reduced its Medpace (MEDP) stake by 7.8% in Q2 2026, selling an estimated $1.85K and leaving 47 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1689.

Private Trust Company first reported a position in MEDP in Q2 2022 and has held it in 17 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Private Trust Company held 47 shares of Medpace worth $24.9K as of Q2 2026.
  • Private Trust Company sold 4 Medpace shares in Q2 2026, an estimated $1.85K.
  • Medpace made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #1689 holding.
  • Private Trust Company first reported a position in Medpace in Q2 2022 and has held it in 17 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.